Neuroscience research on the addictions: A prospectus for future ethical and policy analysis

Addictive Behaviors

Volumn 29, Issue 7, 2004, Pages 1481-1495

  Hall, Wayne ^a   Carter, Lucy ^a   Morley, Katherine I ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Brain disorders; Drug abuse prevention; Drug addiction; Experimental ethics; Neurosciences

Indexed keywords

ADDICTION; CONFERENCE PAPER; DRUG ABUSE; DRUG DEPENDENCE; ETHICS; HUMAN; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL RESEARCH; NEUROSCIENCE; POLICY;

BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETICS AND REPRODUCTION;

ANIMALS; BEHAVIOR, ADDICTIVE; ETHICS, RESEARCH; GENETIC SCREENING; GENOTYPE; HUMAN RIGHTS; HUMANS; NEUROSCIENCES; PUBLIC POLICY; RESEARCH DESIGN; SUBSTANCE-RELATED DISORDERS;

EID: 4444236482     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2004.06.001     Document Type: Conference Paper

References (80)

1. Adler M.W. Human subject issues in drug abuse research. College on problems of drug dependence. Drug and Alcohol Dependence. 37:1995;167-175
2. Alexander J.R., Lerer B., Baron M. Ethical issues in genetic linkage studies of psychiatric disorders. British Journal of Psychiatry. 160:1992;98-102
3. Andrews G., Henderson S., Hall W.D. Prevalence, comorbidity, disability and service utilisation: Overview of the Australian national mental health survey. British Journal of Psychiatry. 178:2001;145-153
4. Anthony J.C., Helzer J. Syndromes of drug abuse and dependence. Robins L.N., Regier D.A. Psychiatric disorders in America. 1991;116-154 Academic Press, New York
5. Australian Law Reform Commission, National Health and Medical Research Council, and Australian Health Ethics Committee Essentially yours: The protection of human genetic information in Australia. vol. 96:2003;Australian Law Reform Commission, Sydney
6. Ball D., Collier D. Substance misuse. McGuffin P., Owen M.J., Gottesman I.I. Psychiatric genetics and genomics. 2002;263-302 Oxford University Press, Oxford
7. Blakemore C. From the "public understanding of science" to scientists' understanding of the public. Marcus S.J. Neuroethics: Mapping the field. 2002;211-221 Dana Press, New York
8. Brody B.A. The ethics of biomedical research: An international perspective. 1998;Oxford University Press, Oxford
9. Cami J., Farre M. Drug addiction. New England Journal of Medicine. 349:2003;975-986
10. Caplan A. No-brainer: Can we cope with the ethical ramifications of new knowledge of the human brain? Marcus S.J. Neuroethics: Mapping the field. 2002;95-106 Dana Press, New York
11. Caplan A. Is better best? Scientific American. 389(3):2003;84-85
12. Carpenter W.T. Jr., Schooler N.R., Kane J.M. The rationale and ethics of medication-free research in schizophrenia. Archives of General Psychiatry. 54:1997;401-407
13. Charland L.C. Cynthia's dilemma: Consenting to heroin prescription. American Journal of Bioethics. 2(2):2002;37-47
14. Cohen P.J. Untreated addiction imposes an ethical bar to recruiting addicts for non-therapeutic studies of addictive drugs. Journal of Law, Medicine and Ethics. 30:2002;73-81
15. Collins D.J., Lapsley H.M. Counting the cost: Estimates of the social costs of drug abuse in Australia in 1998-9. vol. 49:2002;Commonwealth Department of Health and Ageing, Canberra
16. Dolan K., Wodak A., Hall W., Gaughwin M., Rae F. HIV risk behaviour of IDUs before, during and after imprisonment in New South Wales. Addiction Research. 4:1996;151-160
17. Dolinsky Z., Babor T.F. Ethical, scientific and clinical issues in ethanol administration research involving alcoholics as human subjects. Addiction. 92:1997;1087-1097
18. Elliott C. Better than well: American medicine meets the American dream. 2003;W.W. Norton, New York
19. Evans J.P., Skrzynia C., Burke W. The complexities of predictive genetic testing. BMJ. 322:2001;1052-1056
20. Ezzati M., Lopez A.D., Rodgers A., Vander Hoorn S., Murray C.J.L. Selected major risk factors and global and regional burden of disease. Lancet. 360:2002;1347-1360
21. Farah M.J. Emerging ethical issues in neuroscience. Nature Neuroscience. 5:2002;1123-1129
22. Foster K.R., Wolpe P.R., Caplan A.L. Bioethics and the brain. IEEE Spectrum. 40(3):2003;34-39
23. Fox R.G. The compulsion of voluntary treatment in sentencing. Criminal Law Journal. 16:1992;37-54
24. Fu C.H., McGuire P.K. Functional neuroimaging in psychiatry. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 354:1999;1359-1370
25. Fukuyama F. Our posthuman future: Consequences of the biotechnology revolution. 2002;Farrar Straus and Giroux, New York
26. Gerstein D.R., Harwood H.J. Treating drug problems volume 1: A study of effectiveness and financing of public and private drug treatment systems. 1990;Institute of Medicine, National Academy Press, Washington, DC
27. Gilman S. Imaging the brain. First of two parts. New England Journal of Medicine. 338:1998;812-820
28. Gorelick D., Pickens R.W., Benkovsky F.O. Clinical research in substance abuse: Human subjects issues. Pincus H.A., Lieberman J.A., Ferris S. Ethics in psychiatric research: A resource manual for human subjects protection. 1999;177-218 American Psychiatric Association, Washington, DC
29. Greely H.T. Neuroethics and ELSI: Some comparisons and considerations. Marcus S.J. Neuroethics: Mapping the field. 2002;83-91 Dana Press, New York
30. Hall L.L. Medication discontinuation and symptom provocation in research: A consumer and family perspective. Biological Psychiatry. 46:1999;1017-1020
31. Hall S.S. The quest for a smart pill. Scientific American. 289(3):2003;36-45
32. Hall W.D. The role of legal coercion in the treatment of offenders with alcohol and heroin problems. Australian and New Zealand Journal of Criminology. 30:1997;103-120
33. Hall W.D. Taking Darwin seriously: More than telling just so stories. Addiction. 97:2002;472-473
34. Hall W.D., Madden P., Lynskey M. The genetics of tobacco use: Methods, findings and policy implications. Tobacco Control. 11:2002;119-124
35. Hall W.D., Sannibale C. Are there two types of alcoholism? Lancet. 348:1996;1258
36. Healy D. The psychopharmacologists III: Interviews by David Healy. 2001;Edward Arnold Publishers, London
37. Helzer J.E., Burnam A., McEvoy L.T. Alcohol abuse and dependence. Robins L.N., Regier D.A. Psychiatric disorders in America: The epidemiologic catchment area study. 1991;81-115 Free Press, New York
38. Hill E.M., Newlin D.B. Evolutionary approaches to addiction: Introduction. Addiction. 97:2002;375-379
39. Holtzman N.A., Marteau T.M. Will genetics revolutionize medicine? New England Journal of Medicine. 343:2000;141-144
40. Inciardi J.A., McBride D.C. Treatment alternatives to street crime: History, experiences and issues. 1991;National Institute of Drug Abuse, Rockville, MD
41. Independent Working Group on Brain and Mind Disorders Brain and mind disorders: Impact of the neurosciences. 2003;Prime Minister's Science, Engineering and Innovation Council, Canberra
42. Jonsen A.R. The birth of bioethics. 1998;Oxford University Press, Oxford
43. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittshen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Archives of General Psychiatry. 51:1994;8-19
44. Kling M.A., Carson R.E., Borg L., Zametkin A., Matochik J.A., Schluger J., Herscovitch P., Rice K.C., Ho A., Eckleman W.C., Kreek M.J. Opioid receptor imaging with positron emission tomography and [(18)F] cyclofoxy in long-term, methadone-treated former heroin addicts. Journal of Pharmacology and Experimental Therapeutics. 295:2000;1070-1076
45. Kramer P. Listening to Prozac. 1993;Penguin, New York
46. Leshner A.I. Addiction is a brain disease, and it matters. Science. 278:1997;45-47
47. Maldonado R. The neurobiology of addiction. Journal of Neural Transmission. 66:2003;1-14
48. Marteau T.M., Croyle R.T. The new genetics. Psychological responses to genetic testing. BMJ. 316:1998;693-696
49. Martin-Soelch C., Leenders K.L., Chevalley A.F., Missimer J., Kunig G., Magyar S., Mino A., Schultz W. Reward mechanisms in the brain and their role in dependence: Evidence from neurophysiological and neuroimaging studies. Brain Research: Brain Research Reviews. 36:2001;139-149
50. Mauron A. Renovating the house of being: genomes, souls, and selves. Annals of the New York Academy of Sciences. 1001:2003;240-252
51. Munafo M., Johnstone E., Murphy M., Walton R. New directions in the genetic mechanisms underlying nicotine addiction. Addiction Biology. 6:2001;109-117
52. Murray C.J.L., Lopez A.D. Evidence-based health policy: Lessons from the Global Burden of Disease Study. Science. 274:1996;740-743
53. National Academy of Science Pathways of addiction: Opportunities in drug abuse research. 1996;National Academy Press, Washington, DC
54. National Bioethics Advisory Commission Research involving persons with mental disorders that may affect decisionmaking capacity. 1999;National Bioethics Advisory Commission, Rockville, MD
55. National Health and Medical Research Council Ethical aspects of human genetic testing: An information paper. 2000;Author, Canberra
56. National Research Council Informing America's policy on illegal drugs: What we don't know keeps hurting us. 2001;National Academy Press, Washington, DC
57. Nelkin D., Lindee M.S. "Genes made me do it": The appeal of biological explanations. Politics and the Life Sciences. 15:1996;95-97
58. Newman R.G. Involuntary treatment of drug addiction. Bourne P.G. Addiction. 1974;113-126 Academic Press, New York
59. Nuffield Council on Bioethics Mental disorders and genetics: The ethical context. 1998;Author, London
60. Parens E. Is better always good? The enhancement project. Parens E. Enhancing human traits: Ethical and social implications. 1998;1-28 Georgetown University Press, Washington, DC
61. Parens E. How far will the treatment/enhancement distinction get us as we grapple with new ways to shape ourselves? Marcus S.J. Neuroethics: Mapping the field. 2002;152-158 Dana Press, New York
62. Parker L.S. Ethical issues in bipolar disorders pedigree research: Privacy concerns, informed consent, and grounds for waiver. Bipolar Disorders. 4:2002;1-16
63. Porter L., Arif A., Curran W.J. The law and the treatment of drug and alcohol dependent persons: A comparative study of existing legislation. 1986;World Health Organization, Geneva
64. Resnik D.B. The ethics of science: An introduction. 1998;Routledge, London
65. Roberts L.W., Roberts B. Psychiatric research ethics: An overview of evolving guidelines and current ethical dilemmas in the study of mental illness. Biological Psychiatry. 46:1999;1025-1038
66. Roskies A. Neuroethics for the new millennium. Neuron. 35:2002;21-23
67. Ross P. Mind readers. Scientific American. 289(3):2003;54-57
68. Safire W. Visions for a new field of "neuroethics" Marcus S.J. Neuroethics: Mapping the field. 2002;3-9 Dana Press, New York
69. Sell L.A., Morris J., Bearn J., Frackowiak R.S., Friston K.J., Dolan R.J. Activation of reward circuitry in human opiate addicts. European Journal of Neuroscience. 11:1999;1042-1048
70. Shamoo A.E. Ethics in neurobiological research with human subjects: The Baltimore Conference on Ethics. 1998;Gordon and Breach, Amsterdam
71. Spooner C., Hall W.D. Preventing drug misuse by young people: We need to do more than 'just say no'. Addiction. 97:2002;478-481
72. Spooner C., Hall W.D., Mattick R.P. An overview of diversion strategies for Australian drug-related offenders. Drug and Alcohol Review. 20:2001;281-294
73. Stock G. Redesigning humans: Choosing our children's genes. 2002;Profile Books, London
74. Szasz T. Ceremonial chemistry: The ritual persecution of drugs, addicts and pushers. (Revised ed.):1997;Learning Publications, Holmes Beach, FL
75. True W.R., Xian H., Scherrer J.F., Madden P.A., Bucholz K.K., Heath A.C., Eisen S.A., Lyons M.J., Goldberg J., Tsuang M. Common genetic vulnerability for nicotine and alcohol dependence in men. Archives of General Psychiatry. 56:1999;655-661
76. Tyndale R.F. Genetics of alcohol and tobacco use in humans. Annals of Medicine. 35:2003;94-121
77. Valenstein E.S. Blaming the brain: The truth about drugs and mental health. 1998;Free Press, New York
78. Vineis P., Schulte P., McMichael A.J. Misconceptions about the use of genetic tests in populations. Lancet. 357:2001;709-712
79. Walton R., Johnstone E., Munafo M., Neville M., Griffiths S. Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy. Trends in Molecular Medicine. 7:2001;70-76
80. World Health Organization Guidelines for controlling and monitoring the tobacco epidemic. 1998;World Health Organization, Geneva